04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
The U.S. Department of Labor’s new Wage and Hour Administrator Cheryl Stanton recently released her...
Read More >
A seemingly routine Sixth Circuit appeal involving the interpretation of the federal Employee Retire...
Read More >
In recent months, European states have raced to implement protections against opportunistic acquisit...
Read More >
The COVID-19 pandemic has taken a toll on the world's economies and investment activity in 2020—inc...
Read More >
On October 7, 2020, the US Securities and Exchange Commission (“SEC”) adopted a new rule under the...
Read More >
Employer sponsors of 403(b) retirement plans have until March 31, 2020, to amend their plan document...
Read More >